Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Digital twin frameworks for Hepatitis C: Toward predictive, and personalised management
0
Zitationen
2
Autoren
2026
Jahr
Abstract
Despite the availability of antivirals, Hepatitis C remains a major global public health challenge, with over 50 million people living with chronic infection and many remaining undiagnosed or untreated. Transmission persists in marginalised populations, reinfection occurs in high-risk groups, and long-term complications including cirrhosis and hepatocellular carcinoma continue to drive morbidity and mortality. Disease progression, treatment response, and transmission risk are highly heterogeneous and dynamic, shaped by host genetics, immune status, viral kinetics, comorbidities, behavioural exposures, and health-system access. Digital twin, defined as adaptive computational models that continuously mirror an individual's biological and clinical state, offers a transformative approach for predictive and personalised Hepatitis C care. By integrating virological, immunological, biochemical, behavioural, and environmental data, digital twins could enable real-time forecasting of disease progression, optimisation of antiviral therapy, early detection of treatment failure or reinfection, and precision targeting of public-health interventions. This article outlines a conceptual framework for constructing digital twins for Hepatitis C, discusses clinical and population-level applications, and examines the ethical, technical, and translational challenges that must be addressed to support global elimination strategies.
Ähnliche Arbeiten
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
2002 · 6.393 Zit.
Hepatocellular carcinoma
2021 · 6.328 Zit.
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
2001 · 6.048 Zit.
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 · 5.394 Zit.
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 · 4.864 Zit.